CVI 2020 Webinar Series: Management of Severe Calcification – A to Z
December 10, 2020 – December 10, 2021
This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.
The goal of this activity is to provide participants with knowledge and state-of-the-art management information on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.
- Evaluate challenges associated with management of severe coronary calcification .
- Discuss the role of imaging for assessing calcification and the outcome of PCI in heavily calcified lesions .
- Identify various therapeutic strategies for treating heavily calcified lesions .
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.
The CMEsolutions designates this internet activity enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Start Date: December 10, 2020 End Date: December 10, 2021
There is no registration fee for this activity.
- View webinar
- At the end of the webinar, login to: https://online-med-edu.com/cvi2020/webinar/severecalc
- Complete the Evaluation/Credit Request Form-No credit requests will be accepted after December 10, 2021
- Download or Print Credit Statement
FACULTY AND DISCLOSURES
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.
Emmanouil S. Brilakis, MD, PhD
Director, Center for Complex Coronary Interventions, Minneapolis Heart institute
Emmanouil Brilakis has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, CSI, GE Healthcare-Consultant, Speaker's Bureau; Amgen Infra Redx, Teleflex-Speaker Bureau; Regeneron, Siemens Healthineers-Research Grant, Speaker's Bureau; Elsevier-Consultant
Kevin J. Croce, MD, PhD
Cardiologist,Brigham and Women's Hospital
Kevin J. Croce has disclosed the following relevant financial relationships: Abbott, Takeda, Teleflex, CSI-Grant Research Support; Abbott, BSCI, Biotronik, Philips, Abiomed, CSI, Takeda, Cordis-Consultant
Ali E. Denktas, MD
Cardiologist, Memorial Hermann-Texas Medical Center, Baylor St. Luke's Medical Center
Ali E. Denktas has no relevant financial relationships to disclose.
Jaikirshan Khatri, MD
Director of Complex Coronary Intervention, Cleveland Clinic
Jaikirshan Khatri has disclosed the following relevant financial relationships: Abbott-Proctor, Course Faculty; Asahi-Research Funding, Speaker’s Bureau; Boston Scientific-Consultant
Ashish Pershad, MD
Associate Professor of Medicine, Banner University Medical Center and University of Arizona College of Medicine Phoenix
Ashish Pershad has no relevant financial relationships to disclose.
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.
This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
Commercial Support for this educational activity will be provided by the following:
- Boston Scientific